Published 2 hours ago • loading... • Updated 2 hours ago

Big pharma’s next $10 billion gamble: Ozempic for your brain

Summary by Sydney Morning Herald

Could a new class of drugs being used to treat rare neurological disorders allow people to function without sleep?

3 Articles

Sydney Morning Herald

+2 Reposted by 2 other sources

Lean Left

Big pharma’s next $10 billion gamble: Ozempic for your brain

Could a new class of drugs being used to treat rare neurological disorders allow people to function without sleep?

2 hours ago·North Sydney, Australia

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources3

Leaning Left3Leaning Right0Center0Last Updated57 minutes agoBias Distribution

100% Left

Bias Distribution

100% of the sources lean Left

100% Left

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sydney Morning Herald broke the news in North Sydney, Australia 2 hours ago on Monday, August 24, 2026.

Sources are mostly out of (0)

Big pharma’s next $10 billion gamble: Ozempic for your brain

3 Articles

3 Articles

Big pharma’s next $10 billion gamble: Ozempic for your brain

Coverage Details

Bias Distribution

Factuality

Ownership

More stories like this

Anvisa Approves Second Generic of Semaglutide in Brazil

Personalized vaccine helped melanoma patients stay cancer-free longer, drugmakers say

Protect Ozempic & Wegovy From Liver Damage? Study Shows Impressive Effect

Experimental Compound Helps Burn Fat without Muscle Loss

Unexpected GLP-1 Side Effect? Studies Show the Meds May Help People with Addictions

Korea's Top Pharmaceutical Firms Spend over $72.13 Mil. Each in First Hald of the Year for R&D: Data

Similar News Topics

Similar News Topics

More stories like this

Anvisa Approves Second Generic of Semaglutide in Brazil

Personalized vaccine helped melanoma patients stay cancer-free longer, drugmakers say

Protect Ozempic & Wegovy From Liver Damage? Study Shows Impressive Effect

Experimental Compound Helps Burn Fat without Muscle Loss

Unexpected GLP-1 Side Effect? Studies Show the Meds May Help People with Addictions

Korea's Top Pharmaceutical Firms Spend over $72.13 Mil. Each in First Hald of the Year for R&D: Data

Big pharma’s next $10 billion gamble: Ozempic for your brain

The deal underscores growing interest in orexin drugs, which analysts say could become a $US6 billion annual market.

3 Articles

3 Articles

Big pharma’s next $10 billion gamble: Ozempic for your brain

Coverage Details

Bias Distribution Too Big Arrow Icon

Factuality Info Icon

Ownership

More stories like this

Anvisa Approves Second Generic of Semaglutide in Brazil

Personalized vaccine helped melanoma patients stay cancer-free longer, drugmakers say

Protect Ozempic & Wegovy From Liver Damage? Study Shows Impressive Effect

Experimental Compound Helps Burn Fat without Muscle Loss

Unexpected GLP-1 Side Effect? Studies Show the Meds May Help People with Addictions

Korea's Top Pharmaceutical Firms Spend over $72.13 Mil. Each in First Hald of the Year for R&D: Data

Similar News Topics

Similar News Topics

More stories like this

Anvisa Approves Second Generic of Semaglutide in Brazil

Personalized vaccine helped melanoma patients stay cancer-free longer, drugmakers say

Protect Ozempic & Wegovy From Liver Damage? Study Shows Impressive Effect

Experimental Compound Helps Burn Fat without Muscle Loss

Unexpected GLP-1 Side Effect? Studies Show the Meds May Help People with Addictions

Korea's Top Pharmaceutical Firms Spend over $72.13 Mil. Each in First Hald of the Year for R&D: Data

Bias Distribution

Factuality